Claudia C.S. Chini

4.5k total citations · 2 hit papers
40 papers, 3.1k citations indexed

About

Claudia C.S. Chini is a scholar working on Physiology, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Claudia C.S. Chini has authored 40 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 18 papers in Geriatrics and Gerontology and 14 papers in Molecular Biology. Recurrent topics in Claudia C.S. Chini's work include Calcium signaling and nucleotide metabolism (21 papers), Sirtuins and Resveratrol in Medicine (18 papers) and Adenosine and Purinergic Signaling (9 papers). Claudia C.S. Chini is often cited by papers focused on Calcium signaling and nucleotide metabolism (21 papers), Sirtuins and Resveratrol in Medicine (18 papers) and Adenosine and Purinergic Signaling (9 papers). Claudia C.S. Chini collaborates with scholars based in United States, Uruguay and Brazil. Claudia C.S. Chini's co-authors include Eduardo N. Chini, Verónica Nin, Carlos Escande, Mariana G. Tarragó, Gina M. Warner, Kelly A. Hogan, Juliana Camacho-Pereira, Renee A. Schoon, Amrutesh S. Puranik and Antônio Galina and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Claudia C.S. Chini

39 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

2016 616 citations Juliana Camacho-Pereira, Mariana G. Tarragó et al. Cell Metabolism profile →
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases

2019 233 citations Kelly A. Hogan, Claudia C.S. Chini et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia C.S. Chini United States	25	1.1k	1.1k	1.1k	640	618	40	3.1k
Carlos Escande United States	21	918 0.8×	754 0.7×	592 0.6×	379 0.6×	705 1.1×	53	2.3k
Luis A. Rajman United States	8	738 0.7×	1.0k 1.0×	362 0.3×	346 0.5×	561 0.9×	9	2.1k
Verónica Nin United States	17	765 0.7×	645 0.6×	481 0.5×	331 0.5×	425 0.7×	25	1.8k
Carlos Sebastián United States	21	1.5k 1.3×	1.6k 1.5×	366 0.3×	584 0.9×	735 1.2×	35	3.3k
Philip Redpath United Kingdom	14	1.4k 1.3×	983 0.9×	912 0.9×	820 1.3×	554 0.9×	17	2.7k
Elisabeth Berber United States	7	1.4k 1.3×	1.1k 1.1×	325 0.3×	353 0.6×	832 1.3×	8	2.6k
Sadhana Samant United States	23	1.7k 1.6×	1.8k 1.7×	419 0.4×	495 0.8×	883 1.4×	38	3.6k
Hwei-Ling Cheng United States	15	2.4k 2.2×	3.0k 2.8×	407 0.4×	750 1.2×	1.4k 2.2×	23	5.4k
Hwei-Ling Cheng United States	10	1.2k 1.1×	2.2k 2.1×	184 0.2×	650 1.0×	914 1.5×	11	3.4k
Shunsuke Kubota Japan	20	642 0.6×	877 0.8×	305 0.3×	248 0.4×	324 0.5×	49	2.2k

Countries citing papers authored by Claudia C.S. Chini

Since Specialization

Citations

This map shows the geographic impact of Claudia C.S. Chini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia C.S. Chini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia C.S. Chini more than expected).

Fields of papers citing papers by Claudia C.S. Chini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia C.S. Chini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia C.S. Chini. The network helps show where Claudia C.S. Chini may publish in the future.

Co-authorship network of co-authors of Claudia C.S. Chini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia C.S. Chini. A scholar is included among the top collaborators of Claudia C.S. Chini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia C.S. Chini. Claudia C.S. Chini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Bo, Asif Amin, Pranjali Dalvi, et al.. (2023). Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs. Scientific Reports. 13(1). 22085–22085. 5 indexed citations

Zeidler, Julianna D., Kelly A. Hogan, Guillermo Agorrody, et al.. (2022). The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. American Journal of Physiology-Cell Physiology. 322(3). C521–C545. 49 indexed citations

Agorrody, Guillermo, Thais Peclat, Wim van Schooten, et al.. (2022). Benefits in cardiac function by CD38 suppression: Improvement in NAD+ levels, exercise capacity, heart rate variability and protection against catecholamine-induced ventricular arrhythmias. Journal of Molecular and Cellular Cardiology. 166. 11–22. 15 indexed citations

Chini, Claudia C.S., Thais Peclat, Lilian Sales Gomez, et al.. (2022). Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages. Frontiers in Immunology. 13. 840246–840246. 13 indexed citations

Langley, Monica R., Thais Peclat, Yong Guo, et al.. (2021). Critical Role of Astrocyte NAD ⁺ Glycohydrolase in Myelin Injury and Regeneration. Journal of Neuroscience. 41(41). 8644–8667. 23 indexed citations

Chini, Claudia C.S., Julianna D. Zeidler, Sonu Kashyap, Gina Warner, & Eduardo N. Chini. (2021). Evolving concepts in NAD+ metabolism. Cell Metabolism. 33(6). 1076–1087. 165 indexed citations

Colman, Laura, Paola Contreras, Claudia C.S. Chini, et al.. (2019). A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo. Scientific Reports. 9(1). 14381–14381. 8 indexed citations

Hogan, Kelly A., Claudia C.S. Chini, & Eduardo N. Chini. (2019). The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases. Frontiers in Immunology. 10. 1187–1187. 233 indexed citations breakdown →

Chini, Claudia C.S., Kelly A. Hogan, Gina M. Warner, et al.. (2019). The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. Biochemical and Biophysical Research Communications. 513(2). 486–493. 91 indexed citations

10.

Oliveira, Guilherme C. de, Karina S. Kanamori, Maria Auxiliadora‐Martins, Claudia C.S. Chini, & Eduardo N. Chini. (2018). Measuring CD38 Hydrolase and Cyclase Activities: 1,N6-Ethenonicotinamide Adenine Dinucleotide (ε-NAD) and Nicotinamide Guanine Dinucleotide (NGD) Fluorescence-based Methods. BIO-PROTOCOL. 8(14). 13 indexed citations

11.

Tarragó, Mariana G., Claudia C.S. Chini, Karina S. Kanamori, et al.. (2018). A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline. Cell Metabolism. 27(5). 1081–1095.e10. 271 indexed citations

12.

Camacho-Pereira, Juliana, Mariana G. Tarragó, Claudia C.S. Chini, et al.. (2016). CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 23(6). 1127–1139. 616 indexed citations breakdown →

13.

Chini, Claudia C.S., Jair Machado Espíndola‐Netto, Gourish Mondal, et al.. (2015). SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway. Clinical Cancer Research. 22(10). 2496–2507. 33 indexed citations

14.

Warner, Gina, Kyaw Zaw Hein, Verónica Nin, et al.. (2015). Food Restriction Ameliorates the Development of Polycystic Kidney Disease. Journal of the American Society of Nephrology. 27(5). 1437–1447. 132 indexed citations

15.

Chini, Claudia C.S., Verónica Nin, Juliana Camacho-Pereira, et al.. (2013). Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors. Clinical Cancer Research. 20(1). 120–130. 114 indexed citations

16.

Escande, Carlos, Claudia C.S. Chini, Verónica Nin, et al.. (2010). Deleted in breast cancer–1 regulates SIRT1 activity and contributes to high-fat diet–induced liver steatosis in mice. Journal of Clinical Investigation. 120(2). 545–558. 159 indexed citations

17.

Chini, Claudia C.S., Carlos Escande, Verónica Nin, & Eduardo N. Chini. (2010). HDAC3 Is Negatively Regulated by the Nuclear Protein DBC1. Journal of Biological Chemistry. 285(52). 40830–40837. 74 indexed citations

18.

Chini, Eduardo N., Claudia C.S. Chini, Michihisa Jougasaki, et al.. (1997). Cytoprotective effects of adrenomedullin in glomerular cell injury: Central role of cAMP signaling pathway. Kidney International. 52(4). 917–925. 101 indexed citations

19.

Chini, Claudia C.S., Joseph P. Grande, Eduardo N. Chini, & Thomas P. Douša. (1997). Compartmentalization of cAMP Signaling in Mesangial Cells by Phosphodiesterase Isozymes PDE3 and PDE4 REGULATION OF SUPEROXIDATION AND MITOGENESIS. Journal of Biological Chemistry. 272(15). 9854–9859. 61 indexed citations

20.

Matoušovic, K, Joseph P. Grande, Claudia C.S. Chini, Eduardo N. Chini, & Thomas P. Douša. (1995). Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.. Journal of Clinical Investigation. 96(1). 401–410. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact